Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Depression and Gut Health as Signs of Progressive Supranuclear Palsy
March 2026
Large UK Biobank study links depression and gut issues to progressive supranuclear palsy risk up to a decade before diagnosis.
Read more
27 Mar 2026
Depression and Gut Health as Signs of Progressive Supranuclear Palsy
Large UK Biobank study links depression and gut issues to progressive supranuclear palsy risk up to a decade before diagnosis.
26 Mar 2026
Persistent Blood-Brain Barrier Disruption Linked to Cognitive Decline
Athletes with greater BBB disruption showed worse cognitive performance compared with those with less leakage and with control participants.
23 Mar 2026
Parkinson’s Weight Loss: A Hidden Driver of Decline?
Parkinson’s weight loss is increasingly recognised as a key factor in disease progression, linked to frailty, cognitive decline and reduced quality of life.
22 Mar 2026
Rare Spinal AVMs in Youth Respond Well to Treatment
Young adults with rare spinal AVMs show strong recovery after targeted endovascular treatment, guided by MRI and CT imaging of the lesions.
21 Mar 2026
EBV Antibodies Show Promise in Distinguishing MS from MOGAD and NMOSD
Persistent Epstein-Barr virus antibody levels may help distinguish multiple sclerosis from similar neuroinflammatory diseases.
20 Mar 2026
Faecal Microbiota Transplantation Improves Outcomes in Depression
After 2 weeks, patients in the adjunctive FMT group demonstrated significantly greater reductions in HAMD-24 scores compared with controls (p=0.048), alongside a higher overall reduction rate (p=0.016).
19 Mar 2026
Brain Stimulation Shows Promise for OCD
Across the pooled analysis, tES demonstrated a significant moderate therapeutic effect in reducing OCD severity (standardised mean difference: 0.61; 95% confidence interval: 0.37–0.85; p
17 Mar 2026
Study Tracks Early Parkinson’s Symptoms Over Three Years
New research tracks early Parkinson’s symptoms over three years, showing how daily impacts evolve and highlighting the value of wearable monitoring.
Loading posts...
1
2
3
…
59
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View